G

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Senior Director – Portfolio Access and Enablement Lead

Marketing Generalist & ManagementConfirmed live in the last 24 hours
Full-timeFoster City, CA, USA

About the Job

Requirements

  • A Bachelor's degree and at least 14 years of relevant experience in pharmaceutical, biotechnology, healthcare, market access, managed markets, commercial strategy, patient services, reimbursement, payer strategy, marketing, sales, or a related function; alternatively, a Master's degree and at least 12 years of relevant experience in Business, Marketing, Public Health, Life Sciences, Healthcare, or a related field.
  • Significant pharmaceutical, biotechnology, or healthcare commercial experience, with deep expertise in U.S. market access and demonstrated understanding of brand marketing, patient services, reimbursement, payer strategy, and related commercial functions.
  • Demonstrated success leading complex, portfolio-level commercial priorities and influencing senior stakeholders across Marketing, Market Access, Sales, Patient Support, and other cross-functional partners.
  • Strong understanding of patient access and post-prescription journeys, including treatment initiation, access navigation, adherence, persistence, and continuity of care.
  • Experience translating brand objectives and customer needs into access priorities while maintaining clear functional boundaries with Market Access and Patient Support.
  • Strong analytical judgment and ability to synthesize complex data into clear business implications, strategic recommendations, and executive decisions.
  • Exceptional executive influence, communication, change leadership, and cross-functional leadership capabilities.

Responsibilities

  • Own the portfolio-level commercial integration of access priorities across HIV Treatment brands, translating Market Access strategy, payer dynamics, and brand objectives into clear portfolio priorities and execution.
  • Identify, prioritize, and drive action against portfolio access risks and opportunities across national, regional, state, plan, and customer levels.
  • Bring forward brand objectives, customer needs, and commercial implications to inform access strategy and contracting discussions led by Market Access.
  • Establish portfolio access performance frameworks and key performance indicators connecting access conditions, execution, and business impact, and provide clear recommendations to senior leadership and governance forums.
  • Lead the portfolio-level integration and governance of the post-prescription patient access journey in partnership with Patient Support and other functional owners.
  • Identify and prioritize barriers to treatment initiation, access navigation, adherence, persistence, and continuity of care, mobilizing cross-functional solutions that improve patient experience and portfolio performance.
  • Integrate patient journey performance and insights into portfolio strategy, investment priorities, and execution, identifying opportunities to improve access and continuity while maintaining clear functional ownership of regulated Patient Support programs.
  • Own the portfolio approach to access enablement, translating coverage, reimbursement, acquisition, and policy dynamics into clear priorities and actions for brand and customer-facing teams.
  • Identify HCP, office, and field access needs and mobilize solutions that improve customer experience and enable consistent local pull-through.
  • Set priorities for field-facing access communications, training, tools, and resources in partnership with Market Access, Patient Support, Brand Marketing, and Sales leadership.
  • Drive coordinated readiness and activation around significant access changes, ensuring brand and field teams understand the implications, priorities, and required actions.
  • Anticipate and translate state and national healthcare policy and legislative developments into patient, provider, access, and business implications for the HIV Treatment portfolio.
  • Own portfolio readiness for emerging access and policy changes, establishing priorities and mobilizing cross-functional mitigation plans, tools, and communications ahead of anticipated change.
  • Represent HIV Treatment Marketing in enterprise access and policy workstreams, partnering with Government Affairs, Market Access, Managed Markets Marketing, Public Affairs, Medical Affairs, and other functional leaders to drive coordinated portfolio responses.
  • Serve as a senior commercial advisor on portfolio access, bringing clear recommendations and trade-offs to leadership and governance forums to enable timely decision-making.
  • Influence senior cross-functional leaders to align priorities, resolve barriers, and establish clear decision rights and accountability.
  • Build scalable ways of working that increase the speed, consistency, and effectiveness of access execution across the portfolio.
  • Create inclusion by modeling inclusion and embedding the value of diversity in team management.
  • Develop talent by understanding employees' skills, experience, aspirations, and potential, coaching them on current performance and future potential, and ensuring they receive feedback and insight to grow and develop.
  • Empower teams by aligning goals, purpose, and organizational objectives, holding teams accountable, removing barriers, and connecting the team to the broader organization.

About the Company

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Gilead Sciences is a biopharmaceutical company that discovers, develops and sells medicines for HIV, viral hepatitis and other liver diseases, cancer and inflammatory conditions. Its HIV business covers both treatment, led by the once-daily pill Biktarvy, and prevention, including Descovy and Yeztugo, a lenacapavir injection given twice a year. In cancer, its Kite unit makes CAR T-cell therapies from patients' own immune cells, and Trodelvy is an antibody-drug conjugate for breast cancer. Gilead earns revenue by selling its drugs to wholesalers, specialty pharmacies, hospitals and governments worldwide after regulatory approval. The company was founded in 1987 and is headquartered in Foster City, California.

Company size
10,001+
Company stage
IPO
Headquarters
Foster City, CA
Founded
1987

Recently Posted Jobs

Explore more opportunities at Gilead Sciences

See more jobs